RECOMBINANT SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR PROTEINS PROTECT MICE FROM LIPOPOLYSACCHARIDE-INDUCED LETHALITY

被引：255

作者：

LESSLAUER, W ^{[1
]}

TABUCHI, H ^{[1
]}

GENTZ, R ^{[1
]}

BROCKHAUS, M ^{[1
]}

SCHLAEGER, EJ ^{[1
]}

GRAU, G ^{[1
]}

PIGUET, PF ^{[1
]}

POINTAIRE, P ^{[1
]}

VASSALLI, P ^{[1
]}

LOETSCHER, H ^{[1
]}

机构：

[1] UNIV GENEVA,CMU,DEPT PATHOL,CH-1211 GENEVA 4,SWITZERLAND

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 1991年 / 21卷 / 11期

关键词：

D O I：

10.1002/eji.1830211134

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The in vivo efficacy of human recombinant soluble tumor necrosis factor (TNF) receptor protein to prevent and to treat lipopolysaccharide (LPS)-induced lethal toxicity in D-galactosamine-treated mice was investigated. Chimeric proteins of the receptor extracellular domains fused to the hinge region of human IgG3 were expressed in myeloma cells (rsTNFR-h-gamma-3). The fusion proteins had a disulfide-bonded dimeric structure. Upon intravenous injection, their serum concentration decreased relatively slowly after an initial phase of rapid elimination. D-galactosamine-sensitized mice were fully protected from the toxic effects of LPS, if the animal were pretreated with rsTNFR-h-gamma-3 at 20-mu-g/animal. Partial protection was seen at significantly lower doses and when rsTNFR-h-gamma-3 was given up to 3 h after LPS.

引用

页码：2883 / 2886

页数：4

共 24 条

[11] DETECTION OF CIRCULATING TUMOR NECROSIS FACTOR AFTER ENDOTOXIN ADMINISTRATION [J].

MICHIE, HR ;

MANOGUE, KR ;

SPRIGGS, DR ;

REVHAUG, A ;

ODWYER, S ;

DINARELLO, CA ;

CERAMI, A ;

WOLFF, SM ;

WILMORE, DW .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (23) :1481-1486

[12] INTERLEUKIN-1 RECEPTOR ANTAGONIST REDUCES MORTALITY FROM ENDOTOXIN-SHOCK [J].

OHLSSON, K ;

BJORK, P ;

BERGENFELDT, M ;

HAGEMAN, R ;

THOMPSON, RC .

NATURE, 1990, 348 (6301) :550-552

[13] ISOLATION AND CHARACTERIZATION OF A TUMOR NECROSIS FACTOR BINDING-PROTEIN FROM URINE [J].

OLSSON, I ;

LANTZ, M ;

NILSSON, E ;

PEETRE, C ;

THYSELL, H ;

GRUBB, A ;

ADOLF, G .

EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 42 (03) :270-275

[14]

PEETRE C, 1988, EUR J HAEMATOL, V41, P414

[15]

PIGUET PF, 1990, AM J PATHOL, V136, P103

[16] SYNERGY BETWEEN TUMOR NECROSIS FACTOR AND BACTERIAL PRODUCTS CAUSES HEMORRHAGIC NECROSIS AND LETHAL SHOCK IN NORMAL MICE [J].

ROTHSTEIN, JL ;

SCHREIBER, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :607-611

[17] A HUMAN INHIBITOR OF TUMOR NECROSIS FACTOR-ALPHA [J].

SECKINGER, P ;

ISAAZ, S ;

DAYER, JM .

JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1511-1516

[18]

SECKINGER P, 1989, J BIOL CHEM, V264, P11966

[19] PRETREATMENT WITH IBUPROFEN AUGMENTS CIRCULATING TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-6, AND ELASTASE DURING ACUTE ENDOTOXINEMIA [J].

SPINAS, GA ;

BLOESCH, D ;

KELLER, U ;

ZIMMERLI, W ;

CAMMISULI, S .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :89-95

[20]

STARNES HF, 1990, J IMMUNOL, V145, P4185

← 1 2 3 →